Log in or Sign up for Free to view tailored content for your specialty!
Schizophrenia News
GeneSight genetic test yields cost savings for psychiatric patients
A health economic study evaluating the financial impact of the GeneSight combinatorial pharmacogenomic test on major commercial health plans found that use of the test yielded reduced spending for a commercial health plan among patients with psychiatric disorders.
Machine learning model predicts functional outcomes in early-stage mental illness
Findings from a multimodal, multisite machine learning analysis revealed that prediction models determined 1-year social-functioning outcomes in up to 83% of patients at clinical high-risk for psychosis and 70% of patients with recent-onset depression.
Log in or Sign up for Free to view tailored content for your specialty!
FDA accepts sNDA to expand Vraylar indication for bipolar depression
The FDA has accepted Allergan’s supplemental New Drug Application for Vraylar seeking to expand the indication to include the treatment of depressive episodes associated with bipolar I disorder in adults, according to a press release.
Glutamatergic, dopaminergic systems may be related in psychosis
Study findings published in The Lancet Psychiatry showed that the cortical dopaminergic and glutamatergic systems appear related in patients with first-episode psychosis.
Five-factor model best conceptualizes latent structure of negative schizophrenia symptoms
Data from three cross-sectional studies revealed that the latent structure of negative symptoms in schizophrenia was best conceptualized using a five-factor model with separate factors for the five consensus domains issued by NIMH — blunted affect, alogia, anhedonia, avolition and asociality.
Early life adversity tied to poorer social cognition in psychiatric disorders
Findings from a systematic review revealed a significant association between early childhood social adversity — including insecure attachment and adversity relating to neglect or abuse — and poorer social cognitive performance in participants with major psychiatric disorders.
Genetic overlap identified between cannabis use, schizophrenia
Results from a large-scale genetic study showed that some of the same genes linked to cannabis use were also linked to certain psychiatric conditions and personality types.
Cannabidiol may normalize dysfunction in brain regions implicated in psychosis
Study findings showed that a single oral dose of cannabidiol modulated activation in parahippocampal, striatal and midbrain function, which are regions critical to the pathophysiology of psychosis.
Maternal quetiapine exposure may not contribute to malformations in infants
Study results published in the American Journal of Psychiatry indicated that quetiapine exposure during first-trimester pregnancy was not strongly associated with major malformation in infants.
Frequent residential moves during youth may increase psychosis risk
Children and teenagers with more frequent disruption in their residential environments were at higher risk for nonaffective psychosis, according to findings published in JAMA Psychiatry.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read